Endovia Health Sciences (EDVA) Income from Discontinued Operations (2020 - 2026)
Powered by 
Analysis
Endovia Health Sciences (EDVA) Income from Discontinued Operations (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Discontinued) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.47 Bn | 133.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.44 Bn | 78.45 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.94 Bn | 59.76 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.44 Bn | 52.31 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.34 Bn | 44.34 Bn | - | - |
| 6 | BeOne Medicines | 40.35 Bn | 35.25 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.43 Bn | 32.13 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.07 Bn | 27.24 Bn | - | - |
| 9 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn | - |
| 10 | Endovia Health Sciences | 801,166.21 | 558,464.21 | - | -46,393.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -46,393.00 |
| Jun 30, 2025 | -130,599.00 |
| Mar 31, 2025 | 374,237.00 |
| Sep 30, 2022 | 33,116.00 |
| Jun 30, 2022 | 141,053.00 |
| Mar 31, 2022 | -224,576.00 |
| Dec 31, 2021 | 76,140.00 |
| Sep 30, 2021 | -22,077.00 |
| Jun 30, 2021 | 200,404.00 |
| Mar 31, 2021 | 197,488.00 |
| Dec 31, 2020 | -9.15 Mn |
| Sep 30, 2020 | 68,132.00 |
| Jun 30, 2020 | 28,816.00 |